DepoMed, Inc. (DEPO) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
DepoMed, Inc. (NASDAQ: DEPO) reported Q2 EPS of ($0.11), $0.06 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $21.22 million versus the consensus estimate of $22.13 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
- Snowflake (SNOW) Tops Q2 EPS by 17c, Offers Guidance
- PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
